Structure and activation of the large latent transforming growth factor-β complex

International Journal of Obesity

Volumn 20, Issue SUPPL. 3, 1996, Pages

  Nunes, I ^a   Munger, J S ^a   Harpel, J G ^a   Nagano, Y ^a   Shapiro, R L ^a   Gleizes, P E ^a   Rifkin, D B ^a,b  

^a Kaplan Cancer Center   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

(Latent) transforming growth factor ; Activation; Cation independent mannose 6 phosphate insulin like growth factor type II receptor; Large latent complex; Latent transforming growth factor binding protein; Plasmin; Tissue type II transglutaminase

Indexed keywords

PLASMIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

CATTLE; CELL CULTURE; CONFERENCE PAPER; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; MUSCLE FIBER CULTURE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ANIMALS; CATTLE; COCULTURE TECHNIQUES; ENDOTHELIUM; MUSCLE, SMOOTH; PLASMIN; TRANSFORMING GROWTH FACTOR BETA;

BOS TAURUS; BOVINAE;

EID: 0029970264     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Kanzaki T, Olofsson A, Moren A, Werstedt C, Hellman U, Miyazono K, Claesson-Welsh L, Heldin C-H. A component of the large latent complex of TGF-β1 with multiple repeat sequences. Cell 1990; 61: 1051-1061.
2. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 316: 701-705.
3. Purchio AF, Cooper JA, Brunner AM, Lioubin MN, Gentry LE, Kovacina KS, Roth RA, Marquardt H. Identification of mannose 6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-beta 1 precursor. J Biol Chem 1988; 263: 14211-14215.
4. Brunner AM, Gentry LE, Cooper JA, Purchio AF. Recombinant type 1 transforming growth factor beta precursor produced in Chinese hamster ovary cells is glycosylated and phosphorylated. Mol Cell Biol 1988; 8: 2229-2232.
5. Wakefield LM, Smith DM, Flanders KC, Sporn MB. Latent transforming growth factor-β from human platelets. A high molecular weight complex containing precursor sequences. J Biol Chem 1988; 263: 7646-7654.
6. Gentry LE, Lioubin MN, Purchio AF, Marquardt H. Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide. Mol Cell Biol 1988; 8: 4162-4168.
7. Miyazono K, Hellman U, Wernstedt C, Heldin C-H. Latent high molecular weight complex of transforming growth factor-beta 1. Purification from human platelets and structural characterization. J Biol Chem 1988; 263: 6407-6415.
8. Gentry LE, Webb NR, Lim GJ, Brunner AM, Ranchalis JE, Twardzik DR, Lioubin MN, Marquardt H, Purchio AF. Type 1 transforming growth factor beta: amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells. Mol Cell Biol 1987; 7: 3418-3427.
9. Miyazono K, Olofsson A, Colosetti P, Heldin C-H. A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1. EMBO J 1991; 10: 1091-1101.
10. Jennings JC, Mohan S. Heterogeneity of latent transforming growth factor-beta isolated from bone matrix proteins. Endocrinology 1990; 126: 1014-1021.
11. Olofsson A, Miyazono K, Kanzaki T, Colosetti P, Engstrom U, Heldin C-H. Transforming growth factor-beta 1, -beta 2 and -beta 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. J Biol Chem 1992; 267: 19482-19488.
12. Miyazono K, Ichijo H, Heldin C-H. Transforming growth factor-β: latent forms, binding proteins, and receptors. Growth Factors 1993; 8: 11-22.
13. 2+ binding of latent transforming growth factor-β1 binding protein. FEBS Lett 1993; 320: 140-144.
14. Daopin S, Piez KA, Ogawa Y, Davies DR. Crystal structure of transforming growth factor-β2: an unusual fold for the superfamily. Science 1992; 257: 369-373.
15. Massague J. The transforming growth factor-β family. Ann Rev Cell Biol 1990; 6: 597-641.
16. Sporn MB, Roberts AB. Transforming growth factor-β: recent progress and new challenges. J Cell Biol 1992; 119: 1017-1021.
17. Massague J. Receptors for the TGF-β family. Cell 1992; 69: 1067-1070.
18. Serrero G, Mills D. Decrease in transforming growth factor-beta 1 binding during differentiation of rat adipocyte precursors in primary culture. Cell Growth Differ 1991; 2: 173-178.
19. Rosa F, Roberts AB, Danielpour D, Dart LL, Sporn MB, Dawid IB. Mesoderm induction in amphibians: the role of TGF-beta 2-like factors. Science 1988; 239: 783-785.
20. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, Heath JK. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987; 6: 1899-1904.
21. Laiho M, Saksela O, Andreasen PA, Keski-Oja J. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol 1986; 103: 2403-2410.
22. Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE. Thrombospodin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J Biol Chem 1994; 269: 26775-26782.
23. Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J Cell Biol 1988; 106: 1659-1665.
24. Lyons RM, Gentry LE, Purchio AF, Moses HL. Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J Cell Biol 1990; 110: 1361-1367.
25. Brown P, Wakefield L, Levinson A, Sporn M. Physicochemical activation of recombinant latent transforming growth factor-beta's 1,2,3. Growth Factors 1990; 3: 35-43.
26. Oreffo ROC, Mundy GR, Seyedin SM, Bonewald LF. Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. Biochem Biophys Res Commun 1989; 158: 817-823.
27. Sato Y, Rifkin DB. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture. J Cell Biol 1989; 109: 309-315.
28. Twardzik DR, Mikovits JA, Ranchalis JE, Purchio AF, Ellingsworth L, Ruscetti FW. Gamma-interferon-induced activation of latent transforming growth factor-beta by human monocytes. Ann NY Acad Sci 1990; 593: 276-284.
29. Flaumenhaft R, Abe M, Mignatti P, Rifkin DB. Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: regulation of plasminogen activator activity. J Cell Biol 1992; 118: 901-909.
30. Kojima S, Rifkin DB. Mechanism of retinoid-induced activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Physiol 1993; 155: 323-332.
31. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest 1992; 90: 456-461.
32. Piao Y, Ichijo H, Miyagawa K, Ohashi H, Takaku F, Miyazono K. Latent form of transforming growth factor-β1 acts as a potent growth inhibitor on a human erythroleukemia cell line. Biochem Biophys Res Commun 1990; 167: 27-32.
33. Sing GK, Ruscetti FW, Beckwith M, Keller JR, Ellingsworth L, Urba WJ, Longo DL. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate. Cell Growth Differ 1990; 1: 549-557.
34. Kojima S, Harpel PC, Rifkin DB. Lipoprotein(a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration. J Cell Biol 1991; 113: 1439-1445.
35. Stephens RW, Pollanen J, Tapiovaara H, Leung KC, Sim PS, Salonen EM, Ronne E, Behrendt N, Dano K, Vaheri A. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface bound reactants. J Cell Biol 1989; 108: 1987-1995.
36. Odekon LE, Blasi F, Rifkin DR. A requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β. J Cell Physiol 1994; 158: 398-407.
37. Dennis PA, Rifkin DB. Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 1991; 88: 580-584.
38. Appella E, Weber IT, Blasi F. Structure and function of epidermal growth factor-like regions in proteins. FEBS Lett 1988; 231: 1-4.
39. Flaumenhaft R, Abe M, Sato Y, Miyazono K, Harpel JG, Heldin C-H, Rifkin DB. Role of the latent TGF-β binding protein in the activation of latent TGF-β by cocultures of endothelial and smooth muscle cells. J Cell Biol 1993; 120: 995-1002.
40. Kojima S, Nara K, Rifkin DB. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol 1993; 121: 439-448.
41. Bendixen E, Borth W, Harpel PC. Transglutaminases catalyze cross-linking of plasminogen to fibronectin and human endothelial cells. J Biol Chem 1993; 268: 21962-21967.
42. Brown-Augsburger P, Broekelmann T, Mecham L, Mercer R, Gibson MA, Cleary EG, Abrams WR, Rosenbloom J, Mecham RP. Microfibril-associated glycoprotein (MAGP) binds to the carboxy-terminal domain of tropoelastin and is a substrate for transglutaminase. J Biol Chem 1994; 269: 28443-28449.
43. Sato Y, Tsuboi R, Lyons RM, Moses H, Rifkin DB. Characterization of the activation of latent TGF-β by cocultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol 1990; 111: 757-763.
44. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM. Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 1993; 260: 1655-1658.
45. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-β is linked in transgenic apolipoprotein(a) mice. Nature 1994; 370: 460-462.